PRGO Short Volume
Perrigo Company plc (PRGO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $1.51B, listed on NYSE, employing roughly 8,379 people, carrying a beta of 0.54 to the broader market. Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. Led by Patrick Lockwood-Taylor, public since 1991-12-17.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 584.5K
- Total Volume
- 785.2K
- Short %
- 74.44%
- 30-Day Avg Short %
- 49.04%
Showing 30 days of FINRA short volume data for Perrigo Company plc.
Learn how short volume is reported and how to read the data →
Frequently asked PRGO short volume questions
- What is the daily PRGO short volume?
- As of May 15, 2026, Perrigo Company plc (PRGO) short volume is 584.5K shares against 785.2K total reported volume, or 74.44% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is PRGO short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does PRGO short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.